Happy International Women's Day! lnkd.in/ediXjRKm

Just talking to my son and he predicts the Real Madrid score will be 10 nil tonight against Olympiacos

FDA approves perioperative Imfinzi-based regimen - pharmapress.co.uk/fda-approves-p… FDA has approved the combination regimen of durvalumab (Imfinzi, AstraZeneca) with fluorouracil, leucovorin oxaliplatin, and docetaxel (FLOT) chemotherapy as a treatment for patients with early ga...

Denosumab biosimilars in bone-health and oncology now available to European patients - pharmapress.co.uk/denosumab-bios… Stada has received marketing authorisations from the European Commission (EC) for its Kefdensis® and Zvogra® denosumab biosimilars. These approvals for t...

Commercial supply enabled for breast cancer treatment drug - pharmapress.co.uk/commercial-sup… Enzene has announced the initiation of commercial supply of pertuzumab, a monoclonal antibody (mAb) therapy indicated for the treatment of HER2-positive (HER2+) breast cancer. The produc...

Powerful new antibiotic class to tackle deadly superbugs discovered - pharmapress.co.uk/powerful-new-a… Scientists at the University of Liverpool, working with international collaborators, have discovered Novltex, a groundbreaking new class of antibiotics with potent activity agai...

New survey reveals how older Brits are determined to dodge winter viruses - pharmapress.co.uk/new-survey-rev… Pfizer has shared findings from one of its surveys, conducted independently by OnePoll, with 2,000 people aged over 65 across the UK between 21-27 November 2025, which rev...

LogiPharma 2025: curated, collaborative and connected - pharmapress.co.uk/logipharma-202… Following a landmark gathering of over 2,200 life sciences supply chain leaders in April, LogiPharma’s 25th anniversary edition is being recognised not only for its record-breaking ...

New Bedford site - pharmapress.co.uk/new-bedford-si… PCI Pharma Services a world leading global contract development and manufacturing organization (CDMO), introduced its new purpose-built facility at the BIO International Convention, 16-19 June 2025 in Boston. The new facility...

Introducing a world-first 3rd-Generation ELN - pharmapress.co.uk/introducing-a-… Sapio Sciences has announced the launch of the world’s first 3rd-generation Electronic Lab Notebook (ELN) that thinks like a scientist, Sapio ELaiN. Sapio ELaiN is an agentic, AI–powered notebook w...

New deal to expand immune portfolio - pharmapress.co.uk/new-deal-to-ex… Biogen has struck a deal with a new biotechnology company launched by Versant Ventures, for the research and development of experimental drugs for immune conditions. The deal includes a $50 million upfront ...

Data confirms durability and safety of Hemgenix® (etranacogene dezaparvovec) over five years - pharmapress.co.uk/data-confirms-… CSL yesterday announced five-year (60-month) results from the pivotal phase 3 HOPE-B study, confirming the durability and safety of a one-time infusion ...

Study identifies corporate trends of pharma firms - pharmapress.co.uk/study-identifi… The Barclays Business Prosperity Index1 report, combining external research of 500 business leaders and anonymised client data of around 35k UK businesses in health and social care looking back o...

Innovation to help US pharmacies ship confidently - pharmapress.co.uk/innovation-to-… Cold Chain Technologies (CCT), a global leader in temperature-controlled packaging, is transforming how specialty pharmacies manage cold chain logistics with its innovative digital applications -...

Positive results from the phase 3 STRIDE-13 trial evaluating Capvaxive - pharmapress.co.uk/positive-resul… Merck, known as MSD outside of the United States and Canada, announced positive results from the phase 3 STRIDE-13 trial evaluating Capvaxive® (Pneumococcal 21-valent Conjuga...

Natix goes to China to enhance manufacturing - pharmapress.co.uk/natix-goes-to-… To answer the global shortage of high-activity Pancrelipase/Pancreatin Enzybel Pharma 2, Natix has forged a strategic alliance with Deebio, a prominent Chinese manufacturer of enzymes. To meet the ...

Natix goes to China to enhance manufacturing - pharmapress.co.uk/natix-goes-to-… To answer the global shortage of high-activity Pancrelipase/Pancreatin Enzybel Pharma 2, Natix has forged a strategic alliance with Deebio, a prominent Chinese manufacturer of enzymes. To meet the ...

Natix goes to China to enhance manufacturing - pharmapress.co.uk/natix-goes-to-… To answer the global shortage of high-activity Pancrelipase/Pancreatin Enzybel Pharma 2, Natix has forged a strategic alliance with Deebio, a prominent Chinese manufacturer of enzymes. To meet the ...

Natix goes to China to enhance manufacturing - pharmapress.co.uk/natix-goes-to-… To answer the global shortage of high-activity Pancrelipase/Pancreatin Enzybel Pharma 2, Natix has forged a strategic alliance with Deebio, a prominent Chinese manufacturer of enzymes. To meet the ...

Natix goes to China to enhance manufacturing - pharmapress.co.uk/natix-goes-to-… To answer the global shortage of high-activity Pancrelipase/Pancreatin Enzybel Pharma 2, Natix has forged a strategic alliance with Deebio, a prominent Chinese manufacturer of enzymes. To meet the ...